 As Johns Hopkins' first clinical healthcare facility established outside of the United States, the Johns Hopkins Singapore International Medical Centre (JHSIMC) is dedicated to continuing the Hopkins tradition of excellence in research, education and patient care.
Established as a geographical alternative to the Johns Hopkins Hospital in the United States, JHSIMC's healthcare team works together to meet each and every patient's physical, psychological and emotional needs; hence providing high standard of oncology services and care to local and foreign patients.
First opened in 2000 as a state-of-the-art oncology medical centre within the National University Hospital, JHSIMC is now housed in Tan Tock Seng Hospital with 12 chemotherapy treatment beds and 30 inpatient beds.
JHSIMC's services include inpatient care at a private oncology ward, outpatient consultations and chemotherapy, internal medicine consultations/executive health screenings, as well as providing second opinions on complex medical conditions and consultations with referring physicians for specialty services. It treats a wide range of cancers, including but not limited to Breast, Ovarian, Uterine, Cervical, Lung, Throat, Nasopharynx, Stomach, Liver, Kidney, Colon and Lymphoma.
JHSIMC was the first private hospital in Singapore to be awarded the Joint Commission International accreditation in August 2004.
| 
